Table 2

Hematologic response

ResponseImatinib resistantImatinib intolerantTotal
No.%No.%No.%
Cumulative response
    Evaluable patients19988287
    Complete response17286758524786
Cumulative response among patients with no baseline complete hematologic response
    Evaluable patients10041141
    Complete response7676348311078
Reason for exclusion from analysis
    No baseline assessment101